Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2024 Earnings Call Transcript January 29, 2025
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $0.71, expectations were $0.69.
Operator: Hello, and welcome to the Fourth Quarter and Full-Year 2024 Teva Pharmaceutical Industries Earnings Conference Call. My name is Alex, and I’ll be coordinating the call today. [Operator Instructions] I’ll now hand it over to your host, Chris Stevo, SVP, Investor...
